Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-580-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item was not mutagenic in the bacterial reverse mutation study with and without metabolic activation (reference 7.6.1 -1).
The test item was non-mutagenic in mouse lymphoma cells with this screening test system under conditions that exerted potent mutagenic effects for the positive controls (reference 7.6.1 -2).
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 02 -April 04, 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine for S. thyphimurium
tryptophan for E. coli - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : Bioscience Research Laboratory, Kikkoman Corporation (S9; produced on Jan. 11, 1991,Lot No:RAA-248)
- method of preparation of S9 mix: A 9,000 g supernatant (S9), prepared from liver tissue of male Sprague-Dawley rats (7 weeks old) induced with phenobarbital and 5,6-benzoflavone was used. For 1 mL: 0.1 mL S9 + 8 µmol MgCl2 + 33 µmol KCl + 5 µmol G-6-P + 4 µmol NADH + 4 µmol NADPH + 0.5 mL 0.2 M Sodium phosphate buffer (pH 7.4)
- concentration of S9 mix: 0.1 mL S9 in 1 mL S9 mix
- volume of S9 mix added: 0.5 mL per plate with metabolic activation - Test concentrations with justification for top dose:
- 0, 150, 500, 1500 and 5000 µg/plate
- Vehicle / solvent:
- The test substance was dissolved up to 50 mg/mL in acetone, and was used for the assay immediately after diluting with the same solvent.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- furylfuramide
- other: 2-aminoanthracene (2-AA)
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments : 1
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in agar (plate incorporation)
FOR GENE MUTATION:
- Plates were incubated for 48 h at 37 °C.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- not examined - Evaluation criteria:
- The results were judged to be positive when the revertants were twice or more that of the negative control, and when dose dependency or reproducibility were observed in the increase of revertants at least in one strain.
- Statistics:
- The mean of two plates counted was calculated.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Remarks:
- but tested up to the recommended limit concentration
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Remarks:
- but tested up to the recommended limit concentration
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Remarks:
- but tested up to the recommended limit concentration
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Remarks:
- but tested up to the recommended limit concentration
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Ames test:
Please refer to "Attached background material" for:
- Individual plate counts
- Mean number of revertant colonies per plate - Conclusions:
- The test item was not mutagenic in the bacterial reverse mutation study with and without metabolic activation.
- Executive summary:
An in vitro bacterial reverse mutation study was conducted similar to OECD 471. In one plate incorporation test the test item was applied at concentrations of 0, 150, 500, 1500 and 5000 µg/plate to Salmonella typhimurium (TA100, TA1535, TA98, TA1537) and Escherichia coli (WP2 uvrA) strains with and without metabolic activation using S9 mix. There were no increasing number of revertants observed for any strains and any concentration of the test item. The positive control substances increased the number of mutants twice or more the negative control in each strains. Under the test conditions the test item did not show mutagenic potential in the presence and absence of metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Jun 16 - Dec 08, 1998
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- yes
- Principles of method if other than guideline:
- The methodology, originally complying with the ICH guidelines, OECD Test Guideline 476 and Annex V, EEC Directive 79-831, was modified in this study in order to screen a large number of test materials. In brief, the main modification is the use of fewer concentrations of the test material, use of only single cultures per concentration and a simplified data reporting. No quality assurance inspection according to GLP guidelines has been performed.
- GLP compliance:
- no
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- thymidine kinase (TK)
mutation in TK locus remove the 5-trifluorothymidine (TFT) resistance - Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: The original cultures were obtained from Dr. W. Muster, Hoffmann-La Roche, Basel, Switzerland on March 24, 1995. Cells were stored as frozen stocks in liquid nitrogen.
For cell lines:
- Absence of Mycoplasma contamination: yes
- Methods for maintenance in cell culture: flask cultivation
- Periodically ‘cleansed’ of spontaneous mutants: yes
MEDIA USED
- Type and composition of media: growth medium: RPMI-10 (RPMI 1640 with 10% heat-inactivated horse serum)
- Conditions: CO2 concentration 5 % v/v, humiditfied atmosphere, temperature 37 °C - Metabolic activation:
- with and without
- Metabolic activation system:
- 10% rat liver homogenate (S9 mix) with standard co-factors
Type and composition of metabolic activation system:
- source of S9 : Wistar Chbb:THOM rats
- method of preparation of S9 mix: Rats were treated with Aroclor 1254 (500 mg/kg body weight) 5-7 days before sacrifice. Livers were collected, homogenised, centrifuged and the supernatant was collected and stored in liquid nitrogen. On the day of the experiment, glucose-6-phosphate (590 mM), NADP (30 mM), KCI (150 mM) and rat liver S9 were mixed at the ratio of 1:1:1:2.
- cconcentration or volume of S9 mix and S9 in the final culture medium: The final concentration of S9 in the cell culture medium was 2 %. For all cultures treated in the presence of S9 mix, a 1 mL aliquot of the mix was added to each cell culture (19 mL) to give a total of 20 mL.
- quality controls of S9: The bacterial mutagenicity (according to Ames et al., 1975) of 2-amino anthracene, benzo[a]pyrene, and 3-methyl-cholanthrene is determined once for every S9 batch. - Test concentrations with justification for top dose:
- 2.81, 8.89 and 28.1 µg/mL
The highest concentration was selected based on precipitation in the culture medium observed in the range-finding test at >= 8.89 µg/mL and cytotoxicity characteristics of the test material. - Vehicle / solvent:
- - Solvent used: acetone
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- benzo(a)pyrene
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: single for positive control and test item, duplicate for solvent control
- Number of independent experiments : 1 without S9, 2 with S9
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 10^7
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 3 h with S9, 24 h without S9 (in medium, afterwards washing and seeding of cells)
- Harvest time after the end of treatment: survival: 5-8 days, viability: 6-9 days (with subculturing if required), TFT resistance: 9-13 days
FOR GENE MUTATION:
- Expression time: 2 days
- Selection time: 7-11 days
- Selective agent: 5-trifluorothymidine, concentration: 3 µg/mL, duration: 7-11 days (days 3 to 10 or up to day 14 of experiment)
- Number of cells seeded and method to enumerate numbers of viable and mutants cells: viability: 1.6 cells per wells (afterwards growing for 4-7 days), resistance: 2*10^3 cells per well (afterwards growing for 7-11 days); stained with MTT for viable cells
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: cloning efficiency; relative survival (RS) - Evaluation criteria:
- Acceptance criteria
The assay was considered valid if the following criteria were met:
- The mean mutant frequencies in the negative (solvent) control cultures fell within the normal range for this test system and
- at least one concentration of each of the positive control chemicals relevantly increased the mutation frequency as compared to the actual negative control (at least a 2-fold increase).
Test materials are assessed as negative or non-mutagenic in this test system if
- the assay is considered valid and
- no relevant increase in the mutation frequency (at least a 2-fold) occurs.
Test materials are assessed as positive or mutagenic in this test system if
- the assay is considered valid and
- a clear increase in the mutation frequency (at least a 2-fold) occurs dose-dependently (over at least two test material concentrations) or reproducibly at identical concentrations in two independent experimental series performed. - Statistics:
- Not performed
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: observed at 28.1 µg/mL:with S9 at beginning and disolved during exposure time, during the whole time without S9; observed at 15.8 µg/mL: during the whole time with S9
RANGE-FINDING/SCREENING STUDIES: Was condcuted but no details provided.
STUDY RESULTS
please refer to "Attached background material"
HISTORICAL CONTROL DATA: not specified - Conclusions:
- The test item was non-mutagenic in mouse lymphoma cells with this screening test system under conditions that exerted potent mutagenic effects for the positive controls.
- Executive summary:
The test item was screened for its ability to induce mutations at the TK locus (5- trifluorothymidine (TFT) resistance) in mouse lymphoma cells using a fluctuation protocol. The study was conducted in the absence and presence of an exogenous metabolizing system (S9 mix from livers of rats pretreated with Aroclor 1254). The exposure time was 24 hours in the absence and 3 hours in the presence of S9 mix. The top doses to determine TFT resistance in this experiment were selected on the basis of the solubility and cytotoxicity characteristics of the test material. The test item was non-toxic to the mouse lymphoma cells in the absence and presence of S9 mix. Under the different experimental conditions in a range finding test the test item precipitated in the cell culture medium at concentrations between 8.89 and 28.9 µg/mL. Concentrations ranging from 2.81 to 28.1 µg/mL were therefore tested. Negative (solvent) and positive control treatments were included in each mutation experiment in the absence and presence of S9 mix. Mutant frequencies in negative control cultures fell within normal ranges, and clear increases in mutation were induced by the positive control chemicals 4-nitroquinoline N-oxide (without S9 mix) and benzo[a]pyrene (with S9 mix). Therefore the study was accepted as valid. No relevant increases in mutant frequency were observed following treatment with the test item, neither in the absence nor presence of S9 mix. It is therefore concluded that the test item is non-mutagenic in this screening test system under conditions where the positive controls exerted potent mutagenic effects.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the key study an in vitro bacterial reverse mutation study was conducted similar to OECD 471. In one plate incorporation test the test item was applied at concentrations of 0, 150, 500, 1500 and 5000 µg/plate to Salmonella typhimurium (TA100, TA1535, TA98, TA1537) and Escherichia coli (WP2 uvrA) strains with and without metabolic activation using S9 mix. There were no increasing number of revertants observed for any strains and any concentration of the test item. The positive control substances increased the number of mutants twice or more the negative control in each strains. Under the test conditions the test item did not show mutagenic potential in the presence and absence of metabolic activation.
In the supporting study the test item was screened for its ability to induce mutations at the TK locus (5- trifluorothymidine (TFT) resistance) in mouse lymphoma cells using a fluctuation protocol. The study was conducted in the absence and presence of an exogenous metabolizing system (S9 mix from livers of rats pretreated with Aroclor 1254). The exposure time was 24 hours in the absence and 3 hours in the presence of S9 mix. The top doses to determine TFT resistance in this experiment were selected on the basis of the solubility and cytotoxicity characteristics of the test material. The test item was non-toxic to the mouse lymphoma cells in the absence and presence of S9 mix. Under the different experimental conditions in a range finding test the test item precipitated in the cell culture medium at concentrations between 8.89 and 28.9 µg/mL. Concentrations ranging from 2.81 to 28.1 µg/mL were therefore tested. Negative (solvent) and positive control treatments were included in each mutation experiment in the absence and presence of S9 mix. Mutant frequencies in negative control cultures fell within normal ranges, and clear increases in mutation were induced by the positive control chemicals 4-nitroquinoline N-oxide (without S9 mix) and benzo[a]pyrene (with S9 mix). Therefore the study was accepted as valid. No relevant increases in mutant frequency were observed following treatment with the test item, neither in the absence nor presence of S9 mix. It is therefore concluded that the test item is non-mutagenic in this screening test system under conditions where the positive controls exerted potent mutagenic effects.
Justification for classification or non-classification
Classification,
Labelling, and Packaging Regulation (EC) No 1272/2008
The
available experimental test data are reliable and suitable for
classification purposes under Regulation (EC) No 1272/2008. Based on
available data on genotoxicity, the test item does not require
classification according to Regulation (EC) No 1272/2008 (CLP), as
amended for the twelfth time in Regulation (EU) 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
